Skip to content
healthcare.dev

D-33

NDC 58264-0033, ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC, solution, from DNA Labs, Inc..

Product NDC
58264-0033
Status
Listed
Labeler
DNA Labs, Inc.
Dosage form
SOLUTION
Route
SUBLINGUAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0033 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATROPA BELLADONNA30 [hp_X]/mL
  • BUFO BUFO CUTANEOUS GLAND200 [hp_X]/mL
  • COPPER12 [hp_X]/mL
  • ANEMONE PRATENSIS30 [hp_X]/mL
  • SILICON DIOXIDE30 [hp_X]/mL
  • ZINC12 [hp_X]/mL

Pharmacologic classes

Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Inhibit Ovum Fertilization [PE]

Package NDCNDC-11Package
58264-0033-15826400330129.57 mL in 1 BOTTLE, GLASS (58264-0033-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58264-0033 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0033 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58264-0033. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.